Home

Mark J Ahn

CIK 1296543 · President & CEO · last filed 2016-12-15

Mark J Ahn is a President & CEO who has filed 26 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for ABEOW, was dated Dec 15, 2016. Across all open-market trades the lifetime net is −$3.6M, making them a net seller over the disclosed history. 19 SEC filings were submitted jointly with Galena Biopharma, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

26

Lifetime Open-Market Net

-$3.63M

Filer Profile

Reported Address
400 OYSTER POINT BLVD.
SAN FRANCISCO, CA 94080
Related Filers
Galena Biopharma, Inc. — 19 joint filings, latest 2014-09-19
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ABEONA THERAPEUTICS INC. (ABEOW) Delisted Director 493,182 — — $0 2 2016-12-15
ABEONA THERAPEUTICS INC. (ABEO.W) Delisted Director 343,182 — — $100.0K 2 2016-02-16
ABEONA THERAPEUTICS INC. (PTBI.W) Delisted Director 325,000 — — $100.0K 3 2015-06-19
SELLAS Life Sciences Group, Inc. (GALE) Delisted President & CEO 3,874 — — -$3.84M 12 2014-09-19
SELLAS Life Sciences Group, Inc. (RXII) Delisted President and CEO 33 — — $9.5K 6 2011-04-21

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-12-15 ABEONA THERAPEUTICS INC. (ABEOW) Delisted Grant (A) — $0 EDGAR
2016-11-09 ABEONA THERAPEUTICS INC. (ABEOW) Delisted Exer (M) +150,000 $346.5K EDGAR
2016-02-16 ABEONA THERAPEUTICS INC. (ABEO.W) Delisted Grant (A) — $0 EDGAR
2015-08-03 ABEONA THERAPEUTICS INC. (ABEO.W) Delisted Buy (P) +18,182 $100.0K EDGAR
2015-06-19 ABEONA THERAPEUTICS INC. (PTBI.W) Delisted Grant (A) +300,000 $0 EDGAR
2015-05-13 ABEONA THERAPEUTICS INC. (PTBI.W) Delisted Grant (A) +300,000 $2.20M EDGAR
2015-01-26 ABEONA THERAPEUTICS INC. (PTBI.W) Delisted Buy (P) +25,000 $100.0K EDGAR
2014-09-19 SELLAS Life Sciences Group, Inc. (GALE) Delisted Grant (A) +2,461 $6.4K EDGAR
2014-07-02 SELLAS Life Sciences Group, Inc. (GALE) Delisted Other (J) +2,461 $6.4K EDGAR
2014-01-29 SELLAS Life Sciences Group, Inc. (GALE) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.